The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis

INTRODUCTION: Metabolic-associated fatty liver disease (MAFLD) is a hepatic manifestation of metabolic syndrome (MS). MAFLD patients have a higher prevalence of COVID-19. MAFLD also is associated with worse clinical outcomes of COVID-19, such as disease severity, intensive care unit (ICU) admission...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayat, Umar, Ashfaq, Muhammad Zubair, Johnson, Luke, Ford, Ryan, Wuthnow, Chelsea, Kadado, Kevin, El Jurdi, Katia, Okut, Hayrettin, Kilgore, William Ransom, Assi, Maha, Siddiqui, Ali A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Kansas Medical Center 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311786/
https://www.ncbi.nlm.nih.gov/pubmed/35899064
http://dx.doi.org/10.17161/kjm.vol15.16522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311786/
https://www.ncbi.nlm.nih.gov/pubmed/35899064
http://dx.doi.org/10.17161/kjm.vol15.16522

Ejemplares similares